Company ProfilePremium

Global Chinese Business Club

Company Profile Analysis

環球華商俱樂部

ESOMAR 23 Corporate BadgeISO Certifications Badge
Global Chinese Business Club - Company showcase

Year Founded & Workforce

2017

146 Employees

Global Chinese Business Club logo

Global Chinese Business Club Employee Contacts

We don't hold contact details for this company yet — you can request them.

Request Employee Contacts

Global Chinese Business Club Overview

Global Chinese Business Club is a micro-cap Hong Kong foundation-works subcontractor that changed control in October 2025 and is attempting a transformation. All reported revenue still comes from the legacy business: excavation and lateral support (ELS) works, pile caps construction, and ancillary demolition, drainage, earthworks and structural steel works. That business is sold to main contractors on mostly public-sector projects. In FY2026 it generated HK$531.6m of revenue at a 4.4% gross margin and HK$11.0m of net profit. Since October 2025 the new controller, Mainland entrepreneur Zhou Zhenlin, has renamed the company and replaced the board. He has announced pivots into Hong Kong securities brokerage (a 33% associate), Mainland medical aesthetics and wellness, and an O2O e-commerce platform, none of which has yet produced revenue. The share price rose more than forty-fold in nine months and then fell about two-thirds in July 2026. That move, together with an SFC high-concentration warning, makes the equity a speculative, governance-sensitive situation rather than a fundamentally anchored construction stock.


Company's own description (FY2026 Annual Report, paraphrased)

The FY2026 Annual Report (published 31 July 2026) describes the Group as a Hong Kong subcontractor providing foundation-related services. These are ELS works and pile caps construction, plus other services: demolition, underground drainage, earthworks and structural steelworks. To a lesser extent the Group leases machinery to other construction companies. The Report of the Directors lists four principal activities for the subsidiaries:

  • (i) foundation works and construction machinery rental;

  • (ii) financial services;

  • (iii) medical and healthcare services;

  • (iv) e-commerce platform services.

The segment note in the same accounts states that the Group has one operating segment, foundation works in Hong Kong. Only activity (i) generated revenue in FY2026.

Independent characterization

In economic terms, the company is a labour- and plant-intensive second-tier specialist subcontractor. Its customers are main contractors and other construction companies working on public and private projects in Hong Kong.

Revenue model.

  • 100% of FY2026 revenue (HK$531.6m) is construction-contract service revenue recognised over time using an output method. Progress is based on the value of work certified by independent quantity surveyors.

  • There is no product, subscription or licensing revenue.

  • Secondary income is booked as "other income", not revenue. It consists of sales of construction waste (HK$7.7m in FY2026) and machinery rental and transportation income (HK$3.3m in FY2026).

Value-chain position. The company sits below the main contractor and above its own sub-subcontractors. FY2026 subcontracting fees were HK$157.2m, 30.9% of cost of services. Owned plant (PP&E of HK$19.5m net at 31 March 2026) is a competitive input. Pricing is set project by project according to scope and complexity, so margins depend on project mix. Gross margins have ranged from 1.2% to 4.4% over FY2022–FY2026.

Customer types.

  • Main contractors on public works, which accounted for 86.6% of FY2026 revenue (HK$460.4m).

  • Main contractors on private-sector projects, which accounted for 13.4% (HK$71.3m).

  • Concentration is extreme. The largest customer accounted for 33.0% of FY2026 revenue (54.3% in FY2025). The five largest accounted for 85.0% (100.0% in FY2025). Five customers each exceeded 10% of revenue in FY2026, with Customer A at HK$167.2m.

End-markets. Hong Kong public infrastructure and housing (sites cited include Tung Chung, Kai Tak, Siu Lam, Hung Hom, Tseung Kwan O, Fanling and Anderson Road) and private residential and commercial development.

Prospective businesses (announced, pre-revenue as of FY2026):

Financial services: an indirect 33% interest in a Hong Kong company licensed by the SFC for Type 1 regulated activity (dealing in securities). Completed April 2026.

Medical and healthcare (Mainland China): - Medical aesthetics: integrating expert teams, establishing high-end medical aesthetic hospitals, and working with regenerative-medicine institutions.

  • Healthcare and wellness: a planned nationwide chain of wellness stores intended to form a "closed-loop" ecosystem.

E-commerce (Mainland China): an O2O platform combining multi-category transactions, big-data supply-chain management, social-commerce and live-streaming marketing, and B2B/B2C integration.

Strategy

Stated strategic themes (FY2026 Chairman's Statement and MD&A, paraphrased)

  1. Core business: discipline over growth. Keep the focus on foundation works, be more selective about projects to raise margins, and maintain cost control, operational efficiency and risk management. Expand service capability and market share where possible.

  2. Strategic diversification into "new growth engines".

    • Financial services through the 33% broker stake.

    • Mainland medical aesthetics and health and wellness, positioned as aligned with national policies on consumption upgrading and population ageing.

    • An O2O e-commerce platform.

  3. Ecosystem-building through deals. Strategic investment, cooperation and M&A to connect partners along the medical and healthcare value chain, building an "open, collaborative" industrial platform.

  4. Market risk mitigation (legacy). Reduce reliance on government projects by bidding for more private work, and plan new machinery fleets.

Initiative register (last 24 months)

DateInitiativeTypeTargets / commitmentsStatus
15 Oct 2025Change of control to China VCOwnership—Completed
Jan–Feb 2026Rebrand to Global Chinese Business ClubCorporate identity—Completed
13 Mar 2026China integrated O2O e-commerce platformNew business launchNo financial targets disclosedIn development; no revenue
19 Mar 202633% indirect stake in SFC Type 1 licensed brokerInvestment / new businessConsideration not disclosed; HK$1.37m contracted capital commitment at 31 Mar 2026Completed Apr 2026
FY2026 (MD&A); 4 Jun 2026 updateMedical aesthetics hospitals; health & wellness store chain; TCM wellnessNew business launchNo capex or revenue targets disclosedPre-revenue
25 Mar 2026Board lot cut to 1,000 sharesLiquidity measure—Completed
5 Aug 2026CTO and CMO appointments (Peng, Guo)Leadership—Completed
24 Aug 2026New corporate logoBranding—Completed
28 Sep 2026AGM general mandates to issue and repurchase sharesCapital flexibilityStandard mandate limitsApproved (poll results filed)

Guidance and medium-term targets

  • No medium-term financial targets have been published.

  • The only quantitative guidance was the 5 May 2026 positive profit alert: FY2026 profit of HK$8–12m. The actual result was HK$11.0m.

  • Qualitatively, management is "cautiously optimistic" that results can stay stable or improve.

ESG/sustainability commitments: generic (energy-saving equipment, waste reduction). No quantified targets.

Products & Services

The company does not disclose product-level revenue, pricing or brands. The catalog below is built from service descriptions in the FY2022–FY2026 annual results and the FY2026 Annual Report.

Product Portfolio

SegmentService / offeringDescription & capabilitiesTarget customerLaunch / latestPricing model

Foundation works

Excavation & lateral support (ELS) works

Bulk excavation with temporary earth-retaining systems so that basements and pile caps can be built; uses owned excavators and plant

Main contractors (public/private)

Core since inception; ongoing

Contract sum by scope and complexity; progress-billed against QS-certified work

Foundation works

Pile caps construction

Reinforced-concrete caps tying piles to superstructure

Main contractors

Core; ongoing

Contract-based, progress billing

Other services

Demolition works

Removal of existing structures ahead of foundation works

Main contractors

Ongoing

Contract-based

Other services

Underground drainage works

Below-ground drainage installation

Main contractors

Ongoing

Contract-based

Other services

Earthworks

Site cut/fill and soil handling

Main contractors

Ongoing

Contract-based

Other services

Structural steelworks

Steel elements associated with foundation/ELS structures

Main contractors

Ongoing

Contract-based

Ancillary (other income)

Machinery leasing & transportation

Leases owned construction machinery to other contractors (HK$3.3m in FY2026)

Other construction companies

Ongoing

Rental rates (not disclosed)

Ancillary (other income)

Sale of construction waste

Monetisation of excavated/waste materials (HK$7.7m in FY2026)

Recyclers/buyers (not disclosed)

Ongoing

—

Financial services (associate)

Securities dealing (SFC Type 1)

33% indirect stake in a licensed HK broker; broker's name not disclosed in filings reviewed

Retail/corporate investors

Completed Apr 2026

Commission-based (inferred, not disclosed)

Medical & healthcare (planned)

Medical aesthetics ecosystem

High-end medical aesthetic hospitals; expert teams; regenerative medicine collaborations

Mainland consumers

Announced FY2026; pre-revenue

—

Medical & healthcare (planned)

Healthcare & wellness store chain; TCM wellness

Nationwide store clusters; upstream/downstream integration

Mainland consumers (ageing demographic)

Announced FY2026; progress update 4 Jun 2026

—

E-commerce (planned)

Integrated O2O e-commerce platform

Multi-category trading; big-data supply chain; social commerce and live-streaming; B2B+B2C closed loop

Mainland suppliers and consumers

Announced 13 Mar 2026; pre-revenue

—

“—” = not publicly disclosed.

MetricFY2022FY2024FY2026

Projects on hand (number)

191934

Total original contract sum of projects on hand (HKD Mn)

1,6001,2001,400

New contracts awarded in year (number)

5915

New contract value awarded (HKD Mn)

296.0268.0405.0

Projects completed in year (number)

345

Value of projects completed (HKD Mn)

27.0100.1169.9

Financial Narrative

All figures are HK$ millions unless stated. Fiscal years end 31 March. Sources:

  • FY2022 annual results announcement (17 Jun 2022)

  • FY2024 annual results announcement (27 Jun 2024), with FY2023 comparatives

  • FY2026 annual results announcement (29 Jun 2026), with FY2025 comparatives

Operating income is defined as profit before tax plus finance costs. EBITDA is operating income plus depreciation.

Income statement

FY2025 "other income" excludes a HK$0.06m loss on disposal. FY2026 other income excludes a HK$0.87m disposal gain, which is included in EBIT.

Margins

Revenue CAGR:

  • FY2022→FY2026 (4 years): +0.97% p.a.

  • FY2021→FY2026 (5 years, from HK$446.8m): +3.5% p.a.

The flat long-run trend hides very large year-to-year swings: −36%, −39%, +21%, +121%.

Commentary (income statement).

  • FY2026 is the first year since FY2018 with a meaningful profit. Three things drove it: revenue more than doubled, gross margin reached a five-year high of 4.4%, and administrative costs fell for a third straight year to HK$18.6m.

FY2023–FY2025 profits were mostly non-operating: - Other income (construction-waste sales, machinery rental, and in FY2023 HK$5.6m of COVID-19 ESS grants) was 3–4× gross profit.

  • ECL reversals and tax credits supplied the rest. FY2024's HK$2.4m profit included a HK$1.8m prior-year tax over-provision.

FY2026 profit is of higher quality,: coming from gross profit rather than from these items. It still carried a HK$1.9m ECL charge, against a HK$0.3m reversal the year before.

  • The EBITDA margin was stable at 4.4–5.1% across FY2023–FY2026. Falling depreciation (from HK$14.8m in FY2023 to HK$8.8m in FY2026) reflects an ageing, shrinking fleet. It does not reflect efficiency gains.

Finance costs are largely non-cash: In FY2026, HK$1.22m of HK$1.33m was imputed interest on the interest-free former-director loan.

Staff costs are the dominant cost line: They rose 35% to HK$116.8m in FY2026 (FY2025: HK$86.4m). Subcontracting fees tripled to HK$157.2m (FY2025: HK$52.7m), consistent with a volume surge executed partly through subcontractors.

Balance sheet (as at 31 March)

Notes:

  • "Debt" consists almost entirely of amounts due to the former controlling shareholder Mr. Chan Siu Cheong (HK$26.8m at 31 Mar 2026), plus lease liabilities and a bank overdraft (HK$2.0m at FY2025 only).

  • The Group has had no bank borrowings since FY2022.

  • No goodwill or intangibles were recognised through 31 March 2026. The April 2026 associate acquisition will appear in FY2027.

Commentary (balance sheet).

The balance sheet is small and dominated by working capital: Receivables plus contract assets of HK$195.8m make up 85% of total assets.

  • Contract assets (including retentions) rose 35% to HK$126.0m in FY2026 as volumes surged. Advance payments to subcontractors fell from HK$63.9m to HK$24.4m.

Equity grew HK$12.1m to HK$101.3m: This reflects the profit plus a HK$1.1m deemed capital contribution from re-measuring the renewed director loan.

Liquidity depends on the former controller's loan: Cash covered only 38% of the HK$26.8m due to Mr. Chan, all of which was classified as current. The HK$31.5m principal was repayable by 26 September 2026. Whether it was repaid, refinanced or extended after the change of control is a key unresolved item; no announcement was retrieved.

The new controller has not injected equity: No placing or rights issue has taken place since the 2018 IPO.

Cash flow

The full cash-flow statements are on pp. 116–117 of the FY2026 Annual Report and in prior annual reports. Indirect evidence:

  • Cash rose HK$4.4m in FY2026, and the director-loan balance fell HK$7.1m.

  • Implied combined operating and investing inflow is therefore roughly HK$11–14m before lease payments. This is an estimate, not a reported figure.

  • No dividends or buybacks were paid in any year (Reports of the Directors, FY2022–FY2026).

Ratios

Notes:

  • The proxy cash conversion cycle is (trade receivables + contract assets) days minus trade payable days. There is no inventory.

  • All ratios are analyst calculations from the filed statements.

  • FY2021 opening balances (equity HK$77.8m; total assets HK$202.0m) were used for FY2022 averages.

Ratio commentary. FY2026 is an inflection on every return metric: ROE 11.6%, ROIC 10.0%, interest cover 11×, net debt/EBITDA below 1×.

Two caveats temper this:

  1. One year of evidence. The prior four years averaged an ROE of about 2%.

  2. Working-capital release is unlikely to repeat. FY2026's 82-day cycle improved from 107 days mainly because subcontractor advances were released and invoicing was faster. Payable days, however, collapsed from 66 to 27. That suggests the company paid subcontractors faster, possibly at a changed relationship with its dominant subcontractor (85.4% of subcontracting charges in FY2026).

Earlier history (context)

Sources: FY2019 results announcement; FY2022 results announcement (FY2021 comparatives); FY2020 revenue from TipRanks (aggregator).

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Financial Detail

Segment Overview

SegmentContentsProducts/servicesStatus

Foundation works (Hong Kong)

—

ELS works, pile caps construction, demolition, underground drainage, earthworks, structural steelworks; machinery leasing (as other income)

Sole revenue segment

Financial services (associate)

33% of a BVI company wholly owning an SFC Type 1 licensed HK broker

Securities dealing

Equity-accounted from Apr 2026; no FY2026 contribution

Medical & healthcare (planned)

—

Medical aesthetics hospitals; wellness store chain; TCM wellness

Pre-revenue

E-commerce (planned)

—

O2O multi-category platform

Pre-revenue

“—” = not publicly disclosed.

Results by Segment and Segment Margins & Growth (%)

MetricFY2022FY2023FY2024FY2025FY2026

Foundation works revenue (HKD Mn)

511.6326.5199.3240.8531.6

Segment gross profit (HKD Mn)

18.94.04.68.523.3

Segment gross margin (%)

3.71.22.33.54.4

Segment pre-tax profit (HKD Mn, = group)

2.70.20.20.813.3

Revenue YoY growth (%)

14.5-36.2-38.920.8120.8

Contribution to total revenue (%)

100100100100100

Revenue by Segment and Revenue by Segment (%)

MetricFY2022FY2023FY2024FY2025FY2026

Public sector projects revenue (HKD Mn)

291.4315.0145.6237.0460.4

Private sector projects revenue (HKD Mn)

220.211.553.83.871.3

Public sector share of revenue (%)

57.096.573.098.486.6

Private sector share of revenue (%)

43.03.527.01.613.4

Public sector YoY growth (%)

130.68.1-53.862.894.3

Private sector YoY growth (%)

-31.3-94.8368.0-92.91,777.3

Income Statement and Per-Share Data

MetricFY2022FY2023FY2024FY2025FY2026

Revenue (HKD Mn)

511.6326.5199.3240.8531.6

Cost of services (HKD Mn)

492.7322.5194.8232.3508.3

Gross profit (HKD Mn)

18.94.04.68.523.3

Other income (HKD Mn)

5.817.515.513.011.0

Administrative expenses (HKD Mn)

21.822.321.519.418.6

ECL reversal/(impairment), net (HKD Mn)

0.21.93.10.3-1.9

Operating income / EBIT (HKD Mn)

3.11.01.72.414.6

Depreciation (HKD Mn)

13.314.88.39.28.8

EBITDA (HKD Mn)

16.415.810.111.623.5

Finance costs (HKD Mn)

0.40.81.51.61.3

Pre-tax income (HKD Mn)

2.70.20.20.813.3

Income tax credit/(expense) (HKD Mn)

0.30.62.20.3-2.3

Net income attributable (HKD Mn)

3.00.82.41.111.0

EPS basic (HK cents)

0.250.070.200.090.92

EPS diluted (HK cents)

0.250.070.200.090.92

Dividends per share (HK cents)

00000

Margin Analysis (%)

MetricFY2022FY2023FY2024FY2025FY2026

Gross margin (%)

3.691.222.293.524.39

Operating (EBIT) margin (%)

0.610.320.870.982.75

EBITDA margin (%)

3.214.845.054.824.41

Net margin (%)

0.580.251.220.442.08

Income Statement and Operating Metrics (number)

MetricFY2022FY2023FY2024FY2025FY2026

Staff costs incl. directors (HKD Mn)

88.688.772.186.4116.8

Subcontracting charges (HKD Mn)

146.2103.669.352.7157.2

Auditor remuneration (HKD Mn)

1.040.910.750.750.85

Employees at year end (number)

129112113115146

Revenue per employee (HKD Mn)

3.972.921.762.093.64

Balance Sheet and Margin Analysis (%)

MetricFY2022FY2023FY2024FY2025FY2026

Total assets (HKD Mn)

222.8214.2224.1221.1229.7

Property, plant & equipment (HKD Mn)

30.726.124.421.919.5

Trade & other receivables (HKD Mn)

41.574.2104.196.569.7

Contract assets (HKD Mn)

135.394.686.593.2126.0

Cash & equivalents (HKD Mn)

11.917.23.95.710.1

Short-term debt incl. director loan, overdraft, leases (HKD Mn)

41.814.012.938.829.3

Long-term debt incl. director loan, leases (HKD Mn)

1.228.431.40.41.8

Total debt (HKD Mn)

43.042.544.339.231.1

Net debt (HKD Mn)

31.125.240.433.521.0

Total equity (HKD Mn)

80.885.788.189.1101.3

Goodwill & intangibles (HKD Mn)

00000

Working capital / net current assets (HKD Mn)

52.189.593.167.682.6

Reported gearing ratio (%)

53.349.650.341.830.7

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Cash Flow

ItemFY2022FY2023FY2024FY2025FY2026

Capex (HKD Mn, per MD&A)

10.6—4.6—3.6

Free cash flow

Not computable

Not computable

Not computable

Not computable

Not computable

Dividends paid (HKD Mn)

00000

Share buybacks (HKD Mn)

00000

Returns & Leverage Ratios (%) and Financial Ratios (x)

RatioFY2022FY2023FY2024FY2025FY2026

ROE (%, on average equity)

3.730.972.791.1911.59

ROA (%, on average assets)

1.390.371.110.474.90

ROIC (%, NOPAT at 16.5% / year-end equity+net debt)

2.330.781.121.6010.00

Current ratio (x)

1.381.931.921.531.67

Debt / equity (x)

0.530.500.500.440.31

Net debt / EBITDA (x)

1.891.604.012.890.89

Interest coverage, EBIT / finance costs (x)

7.01.31.21.511.1

Asset turnover (x, revenue / average assets)

2.411.490.911.082.36

Receivable days incl. contract assets (days)

107121206173110

Trade payable days on cost of services (days)

3147656627

Proxy cash conversion cycle (days)

767414110782

Income Statement

MetricFY2018FY2019FY2020FY2021

Revenue (HKD Mn)

367.2400.1213.1446.8

Gross profit (HKD Mn)

40.7-42.4—8.9

Pre-tax income (HKD Mn)

21.6-67.8—1.4

Net income (HKD Mn)

———0.65

Revenue by Region and Region Margins & Growth (%)

RegionFY2022FY2023FY2024FY2025FY2026

Hong Kong revenue (HKD Mn)

511.6326.5199.3240.8531.6

Mainland China revenue (HKD Mn)

00000

Rest of world revenue (HKD Mn)

00000

Hong Kong YoY growth (%)

14.5-36.2-38.920.8120.8

Revenue History

Fiscal yearMain revenue drivers (sites)DirectionStated reason

FY2022

Kai Tak, Anderson Road, Yin Ping Road; Tseung Kwan O excavation

Growth

Large projects in full swing; owned machinery used

FY2023

Kai Tak (low margin), Tseung Kwan O

Decline

Major projects winding down

FY2024

Fanling, Tung Chung (commencing)

Decline

Kai Tak and TKO completed; new projects only starting

FY2025

Kai Tak, Tseung Kwan O (low margin)

Recovery

Partial ramp

FY2026

Tung Chung, Kai Tak, Siu Lam, Hung Hom

Strong growth

Sizable projects in full swing; better margins at Tung Chung and Hung Hom

Share Price & Returns

DateClose (HKD)Event / noteSource

15 Oct 2025

0.425

Day of SPA (offer price HK$0.089)

SFC notice cited by company

12 Jan 2026

5.87

+1,281% vs 15 Oct 2025

SFC notice

21 Jan 2026

5.99

+1,309% vs 15 Oct 2025

SFC notice

24 Feb 2026

10.90—

Stoxray

23 Mar 2026

17.78

P/B ≈239×

Simply Wall St

22 May 2026

17.00

Market cap ≈US$2.6bn

Stoxray

30 Jun 2026

17.26

Day after FY2026 results

Lixinger

16 Jul 2026

14.70

Pre-collapse

Lixinger

20 Jul 2026

9.30—

Lixinger

24 Jul 2026

5.80

NED resignation filed

Lixinger

3 Aug 2026

5.40

Volatility ≈234%

Lixinger

Early Oct 2026 (latest)

5.09

Latest observed

etnet

Valuation Multiples

Multiple1757HK construction / heavy-infrastructure reference

Market cap (HKD Mn)

6,108—

Enterprise value (HKD Mn; mkt cap + debt 31.1 − cash 10.1)

6,129—

P/E (trailing, x)

553

≈4.9 (Lixinger Hang Seng heavy-infra sub-industry, Aug 2026)

EV/EBITDA (x)

261—

EV/Sales (x)

11.5—

P/B (x)

60.3

≈0.27 (Lixinger); ≈0.8 industry, 12.6 peer average (Simply Wall St, Mar 2026)

Dividend yield (%)

0

≈5.0 (Lixinger sub-industry)

Capital Markets

ItemStatus

Analyst consensus

None; no sell-side coverage identified

Dividend history & policy

No dividends declared FY2022–FY2026 (and none recommended FY2019 onward per filings reviewed); no formal policy disclosed

Share issuance

No new shares since 2018 IPO; general issuance mandate proposed at 2026 AGM

Credit ratings (Moody's/S&P/Fitch)

Not rated

Debt maturity profile

Former-director loan HK$26.8m carrying amount (HK$31.5m principal) due by 26 Sep 2026; lease liabilities HK$2.5m current, HK$1.8m non-current; no bank borrowings

Liquidity / free float

Free float 25% (300m shares); top 60 holders own 90.61% (22 Jun 2026); thin turnover (e.g., HK$1.3m traded on 3 Aug 2026 per Lixinger)

Analyst Conclusions

Management guidance

  • No numeric guidance for FY2027.

  • Management expresses "cautious optimism" that the construction business can stay stable or grow profit, supported by HK$253.3m of unrecognised contract value (HK$146.3m due within 12 months).

  • New businesses are framed as long-term value creators with no revenue timeline.

Consensus expectations

None. There is no analyst coverage.

Analyst framing: HK$146.3m of backlog due within 12 months is about 28% of FY2026 revenue. Unless new awards match the FY2026 pace (HK$405m), FY2027 construction revenue is likely to decline materially from HK$531.6m. The likely contributors are:

  • in-period burn of new wins;

  • variation orders on the 34 projects on hand.

Bull case

  1. Margin durability plus scale. If gross margin holds above 4% and annual awards stay near HK$400m, the core business can earn HK$8–12m a year without bank debt, as shown in FY2026.

  2. Controller's operating credentials. Mr. Zhou controls a listed company (Junwea Group, 1920.HK) and has two decades in beauty and wellness. That makes a medical-aesthetics injection or asset acquisition plausible, and the listed shell's currency (≈HK$6bn market cap) gives large purchasing power.

  3. Clean balance sheet as a platform. No bank debt, net debt/EBITDA of 0.89× and HK$101m of equity give flexibility. The broker associate adds a licensed financial-services foothold that is scarce and hard to replicate.

Bear case

  1. Valuation detached from fundamentals. At 553× trailing P/E and 60× book, even a ten-fold profit increase would leave the stock above sector multiples. The July 2026 collapse (−61% in six sessions) shows how fragile the price is with 90% of shares in 60 hands.

  2. Core business shrinking into FY2027. Backlog is down 30%, the fleet is ageing (capex HK$3.6m against depreciation of HK$8.8m), the founder-operator has left, and 85% customer concentration combine to point to revenue and margin compression.

  3. Governance and funding overhang. The SFC concentration notice, combined chair/CEO, and an all-owner executive team are concerns. So are three auditors in roughly three years, a HK$31.5m loan from the departed controller due in September 2026, and AGM issuance mandates. Together they imply dilution or related-party transactions may be used to fund the pivots.

Key catalysts and monitorables (next 12 months)

TimingCatalyst / monitorableWhy it matters
Sep–Oct 2026Treatment of HK$31.5m former-director loan (due 26 Sep 2026)Liquidity; signals Chan–Zhou relationship
By 30 Nov 2026Interim results, 6 months to 30 Sep 2026First read on post-FY2026 backlog burn and first equity-accounted broker contribution
OngoingNew contract awards (value, margin, public/private mix)Backlog replenishment
OngoingAnnouncements of medical/wellness or e-commerce acquisitions, including any connected transactions with Zhou-affiliated entitiesDilution, valuation and related-party risk
OngoingUse of the AGM share-issuance mandate (placings)Dilution at elevated prices could recapitalise; at depressed prices, value-destructive
OngoingHigh Court MGO-acceptance caseRegister rectification precedent; governance optics
OngoingSFC/HKEX follow-up on trading or concentrationRegulatory risk
Jun 2027FY2027 annual resultsTest of FY2026 sustainability

Analyst verdict

Global Chinese Business Club is two companies under one ticker.

The first is a small, cyclical Hong Kong foundation subcontractor. FY2026 was its best year since listing: HK$531.6m revenue, a 4.4% gross margin, HK$11.0m profit, and an ROE near 12%. These were earned with no bank debt and with gross profit, rather than subsidies or tax credits, driving profit. On a sector multiple of five to ten times earnings, or roughly book value, that business is worth perhaps HK$60–110m. Its forward trajectory is more likely down than up. Backlog fell 30% to HK$253m, only HK$146m of which converts in the next twelve months. The founder-operator who held customer relationships has left. Customer and subcontractor concentration remain extreme.

The second is a listed vehicle controlled by Mainland entrepreneur Zhou Zhenlin, who paid HK$80m for 75% in October 2025. It has been rebranded around a "global Chinese business club" concept and pointed at medical aesthetics, wellness, e-commerce and brokerage. None of these has generated revenue, budgets or named targets. The market value of about HK$6.1bn at HK$5.09 (after peaking near HK$18–19) therefore assigns roughly HK$6bn to this second company's prospects and to its use as acquisition currency.

The evidence for that value is thin and the governance signals are adverse:

  • an SFC concentration warning;

  • a mandatory offer priced about 79% below market;

  • a full board and auditor replacement within two months;

  • a recombined chair/CEO with an all-owner executive team;

  • a July 2026 price collapse with no disclosed trigger.

Our assessment is that the equity is speculative and not supported by fundamentals. The construction franchise justifies a small fraction of the current price. Any investment case rests entirely on yet-unseen transactions whose terms could just as easily dilute minorities as reward them. Prudent investors should wait for the interim results, the loan resolution, and concrete, independently valued deal terms before engaging.

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Executive Leadership

Board of Directors

NameTitleAppointedAgePrior roles / backgroundEducation

Zhou Zhenlin (周振林)

Chairman, Executive Director, CEO (from 5 Aug 2026); Chairman of Nomination Committee

Chairman/ED 7 Jan 2026

45 (FY2026 AR)

Deputy GM, Shenzhen Jiameiran Technology (skincare/beauty devices) 2004–2011; President, Shenzhen Runfei Technology 2012–2017; Chairman, Tofuls International Holdings Group (health & wellness consulting) since 2017; Chairman, World Chinese Business (Guangdong) Technology since Jun 2023; Chairman, Shihua International Club since Nov 2023; Chairman, ED and controlling shareholder of Junwea Group (China) Co. Ltd (HKEX: 1920)

Executive DBA, University of Montpellier (Mar 2025); business administration course, Guangxi University (2003)

Peng Yunying (彭運英)

Executive Director, Vice Chairlady, Chief Technology Officer

5 Aug 2026

56

30+ years in product R&D and beauty-care operations; Vice Chairlady, Global Chinese Merchants Club (Guangdong) Co., Ltd; senior roles at Shenzhen beauty/technology firms; owns 15% of China VC

MBA, Wrexham University (2021)

Guo Xianjiao (郭顯教)

Executive Director, Vice Chairman, Chief Marketing Officer

5 Aug 2026

56

Brand Director, Guangdong Jianlibao Group; President, Guangdong Tongfu Education Technology Group; owns 10% of China VC

MBA, Wuhan University (2009)

Cheng Shing Yan (鄭承欣)

INED; Audit, Remuneration and Nomination Committee member (named Remuneration Committee chair in one AR table; see note)

15 Jan 2026

51

EY (2004–08), Baker Tilly HK (2009–10), SHINEWING (2010–16); CFO, Sanroc International (1660) group; INED of Putian Communication (1720) and Easy Smart (2442); former INED of 1676, 1413

MA International Accounting, CityU HK; HKICPA, FCCA, ACG, HKCGI

Tsoi Chi Hei (蔡志熙)

INED; Chairman of Audit Committee

15 Jan 2026

38

Poon & Co CPA, SHINEWING, KPMG (manager to Jan 2017); Financial Controller & Co. Sec., Noble Engineering Group (8445) since 2017

HKICPA (CPA, 2014)

Zhou Wencan (周文灿)

INED; Remuneration Committee chair (per AR committee table)

15 Jan 2026

32

Audit Manager, Asia Pacific (Group) CPAs Shenzhen (2015–24); Senior Manager, Zanda (Shenzhen) CPAs (2024–25)

PRC CPA

Tsui Chun Hung (崔隽雄)

Company Secretary

15 Jan 2026

38

Company Secretary of Junwea Group (China) (1920) since 2019

BA (First Class) Accounting, Edinburgh Napier; FCPA (HKICPA)

Zhang Zhang (張章)

Non-executive Director (resigned; see note)

15 Jan 2026

38

BD Manager, Grande Capital (2024–25); VP, Starlight Culture Entertainment (1159) 2014–21; INED, Kingland Group (1751)

BFin, Beijing Technology & Business Univ.; MBA, St. John's University NY

Board of Directors — Chan Siu Cheong

NameFormer roleDeparture

Chan Siu Cheong (陳紹昌)

Founder-controller; Chairman & CEO

Resigned as Chairman 7 Jan 2026; as ED and CEO 15 Jan 2026. Remains creditor (HK$26.8m due at 31 Mar 2026)

Sin Ka Pong (單家邦)

Executive Director

15 Jan 2026

Chan Mei Po (陳美寶)

Executive Director

15 Jan 2026

Ho Chi Wai (何志威)

INED, Audit Committee Chairman

15 Jan 2026

Cheung Kwok Yan Wilfred (張國仁)

INED, Remuneration Committee Chairman

15 Jan 2026

Lau Leong Ho (劉亮豪)

INED

15 Jan 2026

Woo Yuen Ping (胡遠平)

Company Secretary

15 Jan 2026

Governance Overview

ItemDetail

New EDs Peng and Guo

Director's fee of HK$8,000 per month each; 2-year service contracts, auto-renewing for 1 year (announcement 5 Aug 2026)

Total staff costs including directors (FY2026)

HK$116.8m

Equity incentives

Share Option Scheme (adopted 14 May 2018); no options ever granted; 120m shares (10%) available; scheme expires Jun 2028

Major Shareholders

HolderShares% of issuedSource / date

China VC Holdings Ltd (Zhou 75% / Peng 15% / Guo 10%)

900,000,00075.00

FY2026 AR (31 Mar 2026); 25 Jun 2026 announcement

382 shareholders each holding >10,000 shares

260,351,00021.70

25 Jun 2026 voluntary announcement (as at 22 Jun 2026)

Others (86 holders <10,000 shares plus unidentified)

39,649,0003.30

Same

Top 60 shareholders combined (incl. China VC)

1,087,258,00090.61

Same

Insider ownership (directors, via China VC)

900,000,000 (deemed)

75.00

FY2026 AR

Competitive Landscape

Key Competitors

CompetitorHKEX codeSegment overlapLatest revenue (verified)Positioning vs 1757

Vicon Holdings

3,878

Design-and-build foundation (piling, ELS, pile caps), private sector

HK$236.7m (FY2026, YE 31 Mar 2026); backlog HK$163.9m

Private-sector piling specialist; now smaller than 1757 by revenue

Ling Yui Holdings

784

Foundation main contractor/subcontractor (ELS, pile caps, piling, site formation), private sector

HK$214.5m (FY2025, YE 31 Mar 2025)

Private-sector focus; complementary rather than head-to-head on public works

Unnamed 55-year-old HK foundation contractor (HKEX filing 31 Jul 2026, ref. 2026073101217)

—

Piling, ELS, pile caps, site formation

HK$217.9m (FY2026)

—

Sheung Yue Group Holdings

1,633

Piling, ELS, pile caps, site formation (HK & Macau)

—

Broader piling capability

Chinney Kin Wing Holdings

1,556

Foundation and site investigation

—

Larger, diversified foundation player

Kingland Group Holdings

1,751

Foundation/site formation-related works

—

Peer subcontractor (note: former 1757 NED Zhang Zhang is an INED of 1751)

Wan Kei Group

1,718

Foundation and ground investigation

—

Peer

Seven Elements Investment (formerly Sanroc)

1,660

Site formation and excavation

—

Peer (INED Cheng Shing Yan is a Sanroc-group CFO)

Build King Holdings

240

Civil engineering main contractor

—

Potential customer and competitor on integrated packages

Private specialist subcontractors (unlisted)

—

ELS/excavation

—

Price competition in tenders

“—” = not publicly disclosed.

Peer Comparison FY2026

MetricGlobal Chinese Business Club (FY2026)Vicon Holdings (FY2026)Ling Yui Holdings (FY2025)Peer 55-yr contractor (FY2026)

Revenue (HKD Mn)

531.6236.7214.5217.9

Revenue growth (%)

120.8———

Gross margin (%)

4.4———

Net margin (%)

2.1———

R&D intensity (%)

~0 (not disclosed)

~0 (not disclosed)

~0 (not disclosed)

~0 (not disclosed)

Backlog at year end (HKD Mn)

253.3163.9—

49.0 (approx., per filing)

Recent Developments

--

Company Snapshot

$68.2M

Revenue

146

Employees

$780M

Market Cap

2017

Founded

Central, Hong Kong

Headquarters

SWOT Analysis

Strengths

  • Earnings inflection: FY2026 net profit HK$11.0m, about 10× FY2025's HK$1.1m. ROE 11.6% against a four-year average near 2%.
  • Revenue scale recovery: HK$531.6m in FY2026, above the FY2022 peak of HK$511.6m. Fifteen new contracts worth HK$405.0m were won in FY2026.
  • Margin improvement: gross margin rose to 4.4% from 1.2% in FY2023, attributed to selective tendering and better-margin Tung Chung and Hung Hom jobs.
  • No bank debt: gearing (director loan plus leases over equity) fell to 30.7% from 53.3% in FY2022. Net debt/EBITDA was 0.89×.
  • Public-sector anchoring: 86.6% of FY2026 revenue came from public projects, which carry lower counterparty-default risk than private developers.
  • Asset-light overhead: administrative expenses fell for three straight years to HK$18.6m (3.5% of revenue).

Weaknesses

  • Customer concentration: the five largest customers were 85.0% of FY2026 revenue and 100.0% of FY2025 revenue. The largest was 33.0% (54.3% in FY2025).
  • Subcontractor dependence: one subcontractor accounted for 85.4% of FY2026 subcontracting charges; the top five accounted for 94.3%.
  • Thin cash: HK$10.1m of cash against HK$26.8m due to the former director, all current, at 31 Mar 2026.
  • Declining backlog: HK$253.3m unrecognised at 31 Mar 2026, down 30% from HK$361.5m. Only HK$146.3m is expected within one year, about 28% of FY2026 revenue.
  • Ageing fleet: PP&E fell from HK$30.7m (FY2022) to HK$19.5m (FY2026), and FY2026 capex (HK$3.6m) was below depreciation (HK$8.8m).
  • Disclosure quality: the FY2026 AR contains internal inconsistencies, including three of particular note (more in §19.3):
  • The English Chairman's Statement cites gross profit of HK$14.8m; the statements show HK$23.3m.
  • It cites unrecognised contract sum of HK$361.5m; the MD&A and notes show HK$253.3m.
  • The other-income explanations differ between the annual report and the results announcement.

Opportunities

  • Public works pipeline: government development areas (Tung Chung, Kai Tak) have supplied FY2026 growth. Thirty-four projects on hand carry a HK$1.4bn original contract sum.
  • Financial-services associate: the broker stake (completed Apr 2026) adds a non-construction earnings stream and capital-markets capability.
  • Mainland consumer health: the controller's 20+ years in skincare and beauty devices (Shenzhen Jiameiran, Shenzhen Runfei, Junwea Group 1920.HK) could give the medical aesthetics and wellness plan a credible operator base.
  • Listed-platform optionality: AGM general mandates (28 Sep 2026) allow share issuance for acquisitions at a market value of about HK$6bn, far above book value of HK$101m.
  • Private-sector rebound: private revenue rose from HK$3.8m (FY2025) to HK$71.3m (FY2026), offering diversification if HK private construction recovers.
  • Working-capital release: receivable days including contract assets fell to 110 from 173. Further retention collections could fund the loan repayment.

Threats

  • Regulatory scrutiny: the SFC high-concentration notice (22 Jan 2026) found 90.63% of shares in 26 hands. The share price had risen 1,309% between 15 Oct 2025 and 21 Jan 2026.
  • Share-price collapse and volatility: the price fell from HK$14.70 (16 Jul 2026) to HK$5.80 (24 Jul 2026). Lixinger shows annualised volatility above 230% in early August 2026.
  • Litigation: a High Court writ (May 2026) seeks rescission of an offer acceptance and rectification of the share register. A separate subcontractor settlement totals HK$9.4m.
  • Execution risk on pivots: none of the three new businesses had revenue by FY2026, and no budgets have been disclosed.
  • Governance concentration: after Aug 2026 all three EDs are China VC owners; chair and CEO are combined again; and the board, company secretary and auditor were replaced within 2 months (Jan–Mar 2026).
  • Funding gap: the HK$31.5m loan principal fell due on 26 Sep 2026. If the former controller does not extend it, the Group will need new financing or equity.

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Key Developments

DateEventSignificance
Jun 2025FY2025 results: revenue HK$240.8m (+20.8%), profit HK$1.1mBase year for the turnaround
27 Sep 2025HK$31.5m director loan renewed to 26 Sep 2026Liquidity bridge; maturity is now a near-term monitorable
13 Oct 2025Subcontractor lawsuit settled for HK$9.4m (12 instalments)Cash outflow; HK$4.7m paid by 31 Mar 2026
15 Oct 2025China VC acquires 75% for HK$80m (HK$0.089/share)Change of control; triggers MGO
23 Oct 2025Joint announcement of MGOOffer formalised
Nov 2025Interim results (6 months to 30 Sep 2025): revenue ≈HK$349.6m; earnings ≈HK$1.2m (Simply Wall St)Volume surge visible in first half
10 Dec 2025Composite offer document issuedOffer at a fraction of market price; minimal acceptance expected
2 Jan 2026Offer closes with 0.37% acceptance; float 24.63%Public-float breach
7 Jan 2026Zhou Zhenlin appointed Chairman/EDNew leadership
13 Jan 2026Circular proposing name changeRebrand
15 Jan 2026Full board overhaul; new Co. Sec.Governance reset
16–19 Jan 2026HKEX float waiver; China VC places 4.39m shares; float restored to 25%Compliance restored
22 Jan 2026SFC high-concentration notice; company response 23 JanRegulatory red flag; price had risen ~13×
22 Jan 2026Auditor name change announcement (SFAI (HK) → ZSZH (HK) Fuson)Administrative
28 Jan 2026EGM approves name changeRebrand approved
2 Mar 2026Name and stock short-name change effective on HKEXRebrand complete
6 Mar 2026Auditor change to Wilson & Partners; supplemental announcement 8 AprMid-year auditor rotation
13 Mar 2026New business: China O2O e-commerce platformNarrative pivot
19 Mar 2026New business: 33% licensed broker stakeFinancial-services entry
23 Mar 2026Shares at HK$17.78; P/B ≈239× (Simply Wall St)Extreme valuation
25 Mar 2026Board lot cut to 1,000 sharesRetail accessibility
Apr 2026Broker stake completedFirst non-construction asset
5 May 2026Positive profit alert (HK$8–12m)Earnings inflection flagged
May 2026High Court writ over offer acceptanceLitigation (assessed immaterial by company)
4 Jun 2026Progress announcement on medical anti-ageing and TCM wellness–
25 Jun 2026Company states concentration resolved (60 holders = 90.61%)Rebuttal of SFC concern; float still thin
29 Jun 2026FY2026 results: revenue HK$531.6m, profit HK$11.0m, no dividendBest results since FY2018
17–24 Jul 2026Share price falls from HK$14.70 to HK$5.80 (−61% in six sessions)Speculative unwind; cause not disclosed
24 Jul 2026Non-executive director resignsBoard turnover amid price collapse
31 Jul 2026FY2025/26 Annual Report publishedIncludes ESG report
5 Aug 2026Peng and Guo join board as EDs/Vice Chairs; Zhou adds CEO roleOwner-operators take full executive control
24 Aug 2026New logo; AGM circular (general mandates, re-elections, auditor)Rebrand; capital-raising flexibility
26 Sep 2026Scheduled maturity of HK$31.5m former-director loan principalRepayment/extension not confirmed in sources reviewed
28 Sep 2026AGM poll results–
5 Oct 2026Monthly return for September 2026No change in share capital indicated

Financial Performance

Explore key financial metrics, segmented revenue, balance sheet health, and performance trends.

Revenue

5 charts
Income Statement: Revenue & Gross Profit: Revenue rose from HKD 511.6 Mn in FY2022 to HKD 531.6 Mn in FY2026.
Global Chinese Business Club — Income Statement: Revenue & Gross Profit
Series (HKD Mn)FY2022FY2023FY2024FY2025FY2026
Revenue511.6326.5199.3240.8531.6
Cost of services492.7322.5194.8232.3508.3
Gross profit18.944.68.523.3
Revenue per employee42.91.82.13.6

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Unlock Company Contacts

Connect with Key Decision-Makers

Access verified employee contacts and decision-maker information from this company to support your sales, lead generation, and business development efforts.